المؤلفون: Rutgeerts, Paul J, Fedorak, Richard N, Hommes, Daan W, Sturm, Andreas, Baumgart, Daniel C, Bressler, Brian, Schreiber, Stefan, Mansfield, John C, Williams, Marna, Tang, Meina, Visich, Jennifer, Wei, Xiaohui, Keir, Mary, Luca, Diana, Danilenko, Dimitri, Egen, Jackson, O'Byrne, Sharon

المصدر: Gut. 62(8)

مصطلحات موضوعية: Inflammatory Bowel Disease, Biotechnology, Clinical Trials and Supportive Activities, Clinical Research, Digestive Diseases, Autoimmune Disease, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Adolescent, Adult, Aged, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Colitis, Ulcerative, Dose-Response Relationship, Drug, Double-Blind Method, Female, Gastrointestinal Agents, Humans, Infusions, Intravenous, Injections, Subcutaneous, Male, Middle Aged, Severity of Illness Index, Treatment Outcome, Young Adult, Etrolizumab, rhuMAb 7, ulcerative colitis, drug development, safety, pharmacokinetics, IBD clinical, IBD basic research, IBD, IBD models, apoptosis, cell cycle, immunology, inflammatory bowel disorders, dendritic cells, Crohn's disease, cytokines, genetics, signal transduction, IBD-genetics, antibody targeted therapy, arthritis, autoimmune disease, integrins, IBD–genetics, rhuMAb β7, Clinical Sciences, Paediatrics and Reproductive Medicine, Gastroenterology & Hepatology

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/4j41q864

المؤلفون: Stefan Schreiber, Richard N. Fedorak, Mary E. Keir, Daan W. Hommes, Sharon O'Byrne, Meina Tang, Daniel C. Baumgart, Diana Luca, Paul Rutgeerts, John C. Mansfield, Brian Bressler, Andreas Sturm, Dimitri Danilenko, Marna Williams, Xiaohui Wei, Jackson G. Egen, Jennifer Visich

المصدر: Gut, vol 62, iss 8

مصطلحات موضوعية: Male, Ulcerative, Gastroenterology, rhuMAb 7, Severity of Illness Index, immunology, Monoclonal, Medicine, Etrolizumab, genetics, Stage (cooking), IBD models, Infusions, Intravenous, Humanized, Subcutaneous, apoptosis, Antibodies, Monoclonal, Crohns disease, Middle Aged, Colitis, Ulcerative colitis, inflammatory bowel disorders, Phase i study, Crohn's disease, Treatment Outcome, arthritis, 6.1 Pharmaceuticals, Cohort, cell cycle, Female, Drug, IBD–genetics, Intravenous, pharmacokinetics, signal transduction, Biotechnology, safety, Adult, medicine.medical_specialty, Infusions, Adolescent, Injections, Subcutaneous, Clinical Trials and Supportive Activities, IBD, Clinical Sciences, autoimmune disease, Placebo, Antibodies, Monoclonal, Humanized, Antibodies, Injections, Dose-Response Relationship, Paediatrics and Reproductive Medicine, Young Adult, Pharmacokinetics, Double-Blind Method, Gastrointestinal Agents, Clinical Research, Internal medicine, Humans, dendritic cells, Adverse effect, ulcerative colitis, Aged, Gastroenterology & Hepatology, Dose-Response Relationship, Drug, business.industry, Inflammatory Bowel Disease, IBD-genetics, Evaluation of treatments and therapeutic interventions, rhuMAb β7, medicine.disease, drug development, cytokines, Surgery, antibody targeted therapy, IBD clinical, IBD basic research, integrins, Colitis, Ulcerative, Digestive Diseases, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::787c54c20ba00b618f09e98e02b8226e
https://pubmed.ncbi.nlm.nih.gov/24269566

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.